Oaktree Specialty Lending Corp (OCSL) Stock Price & Analysis
Oaktree Specialty Lending Corp (OCSL) rose 0.34% to USD 11.91 as of June 10, 2026 at 00:38 UTC, according to Nexqual real-time market data.
OCSL last closed at USD 11.87; the session ranged USD 11.85–12.04 on volume of 525,651 shares. Market capitalization is $1.05B, with a 52-week range of USD 10.63–14.77 (NMS). Source: Nexqual, June 10, 2026 at 00:38 UTC.
Key Statistics (as of June 10, 2026 at 00:38 UTC)
| Price | USD 11.91 |
|---|---|
| Change | ▲ 0.34% (up) |
| Previous Close | USD 11.87 |
| Open | USD 11.87 |
| Day Range | USD 11.85 – 12.04 |
| 52-Week Range | USD 10.63 – 14.77 |
| Volume | 525,651 shares |
| Market Cap | $1.05B |
| Exchange | NMS |
Technical Analysis (OCSL)
Nexqual's technical model rates OCSL "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 00:38 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 44.29 (neutral) |
| vs SMA50 | Below (USD 12.13) |
| MACD | -0.05 (negative) |
Analyst Ratings (OCSL)
Wall Street analysts rate OCSL "None" based on 6 analysts, with a mean price target of USD 12.43 (range USD 11.5–13.5), per Nexqual as of June 10, 2026 at 00:38 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 6 |
| Mean Target | USD 12.43 |
| High Target | USD 13.5 |
| Low Target | USD 11.5 |
| Buy / Hold / Sell | 0 / 7 / 0 |
Earnings (OCSL)
| Next Earnings Date | 2026-08-04 |
|---|---|
| EPS Estimate | USD 0.36 |
| Revenue Estimate | $69.40M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.38 vs est 0.37 ▲ beat |
| 2025-12-31 | USD 0.41 vs est 0.38 ▲ beat |
| 2025-09-30 | USD 0.4 vs est 0.39 ▲ beat |
| 2025-06-30 | USD 0.37 vs est 0.45 ▼ miss |
Source: Nexqual, June 10, 2026 at 00:38 UTC.
Financials & Fundamentals (OCSL)
| Total Revenue | $298.07M |
|---|---|
| Revenue Growth (YoY) | -9.30% |
| Gross Margin | +100.00% |
| Operating Margin | +85.23% |
| Profit Margin | +16.66% |
| ROE | +3.48% |
| Debt / Equity | 107.62 |
| Current Ratio | 4.8 |
| Total Cash | $51.26M |
| Total Debt | $1.49B |
| Free Cash Flow | $-4.65M |
Source: Nexqual, June 10, 2026 at 00:38 UTC.
Financial Health Score (OCSL)
Nexqual rates Oaktree Specialty Lending Corp's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 00:38 UTC.
| Growth | Critical — Revenue -17% YoY (annual), sharp decline |
|---|---|
| Profitability | Strong — Operating margin 85% |
| Balance Sheet | Mixed — $51M cash vs $1.49B debt |
| Cash Flow | Weak — FCF negative: -$5M, burning cash |
| Efficiency | Weak — ROE 3%, ROA 5.2% |
Ownership (OCSL)
| Insider Ownership | +0.30% |
|---|---|
| Institutional Ownership | +42.55% |
| Shares Outstanding | 88.09M |
| Short % of Float | +3.61% |
Source: Nexqual, June 10, 2026 at 00:38 UTC.
Leadership (OCSL)
Oaktree Specialty Lending Corp is led by Armen Panossian (age 49), CEO & Co-Chief Investment Officer, per Nexqual as of June 10, 2026 at 00:38 UTC.
| CEO & Co-Chief Investment Officer | Armen Panossian (age 49) |
|---|---|
| President | Mathew M. Pendo (age 61) |
| Managing Director & Co-Portfolio Manager of Life Sciences Direct Lending | Aman Kumar (age 44) |
| CFO & Treasurer | Christopher McKown (age 43) |
| Chief Operating Officer | Brett McKeone |
Major Backers & Investors (OCSL)
Notable institutional backers of Oaktree Specialty Lending Corp include Private Management Group, Inc., Morgan Stanley, Bruni J V & Co /CO, according to Nexqual as of June 10, 2026 at 00:38 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Private Management Group, Inc. | 4.22% |
| Morgan Stanley | 2.91% |
| Bruni J V & Co /CO | 2.84% |
| Ares Management LLC | 2.38% |
| Generali Asset Management Spa Sgr | 2.37% |
| Oaktree Capital Management LP | 2.1% |
| Van Eck Associates Corporation | 1.93% |
| Claret Asset Management Corp | 1.89% |
Source: Nexqual, June 10, 2026 at 00:38 UTC.
From Oaktree Specialty Lending Corp's Latest SEC 10-K Filing (filed 2025-11-18)
Key Strengths & Strategy (as disclosed to the SEC)
- Oaktree Specialty Lending Corporation is a business development company.
- The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies.
- It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering.
- The firm also seeks investment in media, advertising sectors, software, IT services, pharmaceuticals, biotechnology, real estate management and development, chemicals, machinery, and internet and direct marketing retail sectors.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TSLX | Sixth Street Specialty Lending, | USD 17.22 | ▼ 0.98% |
| BBDC | Barings BDC, Inc. | USD 8.46 | ▲ 1.44% |
| TPVG | TriplePoint Venture Growth BDC | USD 5.47 | ▲ 1.86% |
| GBDC | Golub Capital BDC, Inc. | USD 13.1 | ▲ 0.46% |
| CGBD | Carlyle Secured Lending, Inc. | USD 10.78 | ▲ 1.32% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:38 UTC. This page is informational and not investment advice.